A Phase I Study of Surgery Plus Intraoperative Photodynamic Therapy (PDT) in Patients With Resectable, Primary or Recurrent Head and Neck Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT00470496

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:38:34.056399+00:00

Published At

2022-07-25T00:00:00+00:00

Record Updated At

2022-07-25

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Recurrent Adenoid Cystic Carcinoma of the Oral Cavity", "Recurrent Basal Cell Carcinoma of the Lip", "Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity", "Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity", "Recurrent Lymphoepithelioma of the Nasopharynx", "Recurrent Lymphoepithelioma of the Oropharynx", "Recurrent Metastatic Squamous Neck Cancer With Occult Primary", "Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity", "Recurrent Mucoepidermoid Carcinoma of the Oral Cavity", "Recurrent Salivary Gland Cancer", "Recurrent Squamous Cell Carcinoma of the Hypopharynx", "Recurrent Squamous Cell Carcinoma of the Larynx", "Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity", "Recurrent Squamous Cell Carcinoma of the Nasopharynx", "Recurrent Squamous Cell Carcinoma of the Oropharynx", "Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity", "Recurrent Thyroid Cancer", "Recurrent Verrucous Carcinoma of the Larynx", "Recurrent Verrucous Carcinoma of the Oral Cavity", "Stage I Adenoid Cystic Carcinoma of the Oral Cavity", "Stage I Basal Cell Carcinoma of the Lip", "Stage I Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity", "Stage I Follicular Thyroid Cancer", "Stage I Inverted Papilloma of the Paranasal Sinus and Nasal Cavity", "Stage I Lymphoepithelioma of the Nasopharynx", "Stage I Lymphoepithelioma of the Oropharynx", "Stage I Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity", "Stage I Mucoepidermoid Carcinoma of the Oral Cavity", "Stage I Papillary Thyroid Cancer", "Stage I Salivary Gland Cancer", "Stage I Squamous Cell Carcinoma of the Hypopharynx", "Stage I Squamous Cell Carcinoma of the Larynx", "Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity", "Stage I Squamous Cell Carcinoma of the Oropharynx", "Stage I Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity", "Stage I Verrucous Carcinoma of the Larynx", "Stage I Verrucous Carcinoma of the Oral Cavity", "Stage II Adenoid Cystic Carcinoma of the Oral Cavity", "Stage II Basal Cell Carcinoma of the Lip", "Stage II Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity", "Stage II Follicular Thyroid Cancer", "Stage II Inverted Papilloma of the Paranasal Sinus and Nasal Cavity", "Stage II Lymphoepithelioma of the Nasopharynx", "Stage II Lymphoepithelioma of the Oropharynx", "Stage II Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity", "Stage II Mucoepidermoid Carcinoma of the Oral Cavity", "Stage II Papillary Thyroid Cancer", "Stage II Salivary Gland Cancer", "Stage II Squamous Cell Carcinoma of the Hypopharynx", "Stage II Squamous Cell Carcinoma of the Larynx", "Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity", "Stage II Squamous Cell Carcinoma of the Oropharynx", "Stage II Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity", "Stage II Verrucous Carcinoma of the Larynx", "Stage II Verrucous Carcinoma of the Oral Cavity"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2022-07-25"

protocolSection.identificationModule.nctId

"NCT00470496"

protocolSection.identificationModule.officialTitle

"A Phase I Study of Surgery Plus Intraoperative Photodynamic Therapy (PDT) in Patients With Resectable, Primary or Recurrent Head and Neck Cancer"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Recurrent Adenoid Cystic Carcinoma of the Oral Cavity (protocolSection.conditionsModule.conditions)
• Recurrent Basal Cell Carcinoma of the Lip (protocolSection.conditionsModule.conditions)
• Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity (protocolSection.conditionsModule.conditions)
• Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity (protocolSection.conditionsModule.conditions)
• Recurrent Lymphoepithelioma of the Nasopharynx (protocolSection.conditionsModule.conditions)
• Recurrent Lymphoepithelioma of the Oropharynx (protocolSection.conditionsModule.conditions)
• Recurrent Metastatic Squamous Neck Cancer With Occult Primary (protocolSection.conditionsModule.conditions)
• Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity (protocolSection.conditionsModule.conditions)
• Recurrent Mucoepidermoid Carcinoma of the Oral Cavity (protocolSection.conditionsModule.conditions)
• Recurrent Salivary Gland Cancer (protocolSection.conditionsModule.conditions)
• Recurrent Squamous Cell Carcinoma of the Hypopharynx (protocolSection.conditionsModule.conditions)
• Recurrent Squamous Cell Carcinoma of the Larynx (protocolSection.conditionsModule.conditions)
• Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity (protocolSection.conditionsModule.conditions)
• Recurrent Squamous Cell Carcinoma of the Nasopharynx (protocolSection.conditionsModule.conditions)
• Recurrent Squamous Cell Carcinoma of the Oropharynx (protocolSection.conditionsModule.conditions)
• Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity (protocolSection.conditionsModule.conditions)
• Recurrent Thyroid Cancer (protocolSection.conditionsModule.conditions)
• Recurrent Verrucous Carcinoma of the Larynx (protocolSection.conditionsModule.conditions)
• Recurrent Verrucous Carcinoma of the Oral Cavity (protocolSection.conditionsModule.conditions)
• Stage I Adenoid Cystic Carcinoma of the Oral Cavity (protocolSection.conditionsModule.conditions)
• Stage I Basal Cell Carcinoma of the Lip (protocolSection.conditionsModule.conditions)
• Stage I Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity (protocolSection.conditionsModule.conditions)
• Stage I Follicular Thyroid Cancer (protocolSection.conditionsModule.conditions)
• Stage I Inverted Papilloma of the Paranasal Sinus and Nasal Cavity (protocolSection.conditionsModule.conditions)
• Stage I Lymphoepithelioma of the Nasopharynx (protocolSection.conditionsModule.conditions)
• Stage I Lymphoepithelioma of the Oropharynx (protocolSection.conditionsModule.conditions)
• Stage I Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity (protocolSection.conditionsModule.conditions)
• Stage I Mucoepidermoid Carcinoma of the Oral Cavity (protocolSection.conditionsModule.conditions)
• Stage I Papillary Thyroid Cancer (protocolSection.conditionsModule.conditions)
• Stage I Salivary Gland Cancer (protocolSection.conditionsModule.conditions)
• Stage I Squamous Cell Carcinoma of the Hypopharynx (protocolSection.conditionsModule.conditions)
• Stage I Squamous Cell Carcinoma of the Larynx (protocolSection.conditionsModule.conditions)
• Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity (protocolSection.conditionsModule.conditions)
• Stage I Squamous Cell Carcinoma of the Oropharynx (protocolSection.conditionsModule.conditions)
• Stage I Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity (protocolSection.conditionsModule.conditions)
• Stage I Verrucous Carcinoma of the Larynx (protocolSection.conditionsModule.conditions)
• Stage I Verrucous Carcinoma of the Oral Cavity (protocolSection.conditionsModule.conditions)
• Stage II Adenoid Cystic Carcinoma of the Oral Cavity (protocolSection.conditionsModule.conditions)
• Stage II Basal Cell Carcinoma of the Lip (protocolSection.conditionsModule.conditions)
• Stage II Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity (protocolSection.conditionsModule.conditions)
• Stage II Follicular Thyroid Cancer (protocolSection.conditionsModule.conditions)
• Stage II Inverted Papilloma of the Paranasal Sinus and Nasal Cavity (protocolSection.conditionsModule.conditions)
• Stage II Lymphoepithelioma of the Nasopharynx (protocolSection.conditionsModule.conditions)
• Stage II Lymphoepithelioma of the Oropharynx (protocolSection.conditionsModule.conditions)
• Stage II Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity (protocolSection.conditionsModule.conditions)
• Stage II Mucoepidermoid Carcinoma of the Oral Cavity (protocolSection.conditionsModule.conditions)
• Stage II Papillary Thyroid Cancer (protocolSection.conditionsModule.conditions)
• Stage II Salivary Gland Cancer (protocolSection.conditionsModule.conditions)
• Stage II Squamous Cell Carcinoma of the Hypopharynx (protocolSection.conditionsModule.conditions)
• Stage II Squamous Cell Carcinoma of the Larynx (protocolSection.conditionsModule.conditions)
• Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity (protocolSection.conditionsModule.conditions)
• Stage II Squamous Cell Carcinoma of the Oropharynx (protocolSection.conditionsModule.conditions)
• Stage II Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity (protocolSection.conditionsModule.conditions)
• Stage II Verrucous Carcinoma of the Larynx (protocolSection.conditionsModule.conditions)
• Stage II Verrucous Carcinoma of the Oral Cavity (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.